SERO is a leading force in radiation oncology in the Carolinas, with over 40 years of dedication to innovation and patient care. Home to more than 30 board-certified radiation oncologists in the greater Charlotte Metro area, SERO operates 20 cancer treatment centers across North and South Carolina. Their team of prominent cancer doctors takes pride in serving patients across the Southeast U.S. in the health care industry. Established in 1977, SERO continues to be at the forefront of cancer treatment and care. With a last investment and investors yet to be disclosed, the company's stronghold in the region's oncology landscape makes it an attractive prospect for potential investors.
General Information
Get notified when SERO moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
United States Market
Health Care
About SERO
Taxonomy: Radiation Oncology, Cancer Treatment, Oncologists, Radiation Therapy, Brachytherapy, Cyberknife Radiation, Intensity-Modulated Radiation Therapy, Image-Guided Radiation Therapy, Brain Tumor Treatment, Breast Cancer Treatment, Colorectal Cancer Treatment, Gynecologic Cancer Treatment, Head and Neck Cancer Treatment, Lung Cancer Treatment, Prostate Cancer Treatment
No funding data available for SERO yet.
Get notified when SERO raises fundingSERO Alternatives & Competitors
With 20+ years of experience fighting cancer, we encourage you to call us for relief.
An innovative leader in cancer molecular diagnostics, delivering personalized radiation therapy to e...
FAQ About SERO
Don't just browse. Track.
Signal Tracker monitors SERO and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.